Gene Panel Market Share, Analysis, Trend, Size, Growth till 2027

 

Gene panel is a test that analyzes multiple genes for cancer-associated mutations at the same time. Gene panels offer a middle ground between single-gene sequencing (like BRCA1), which is certainly involved in disease risk and sequencing every gene in the genome. Gene panels enable the simultaneous screening of several genes.

The gene panel market in the global market is expected to grow at a high CAGR of 12.16% by the end of the forecasted period to account for a higher market value of approximately USD 4,347.32 million during the forecasted period in the global market.

Panels are typically customized for specific screening purposes; thus, the genes and specific gene regions on such panels are unique to the screening goals. The increasing prevalence of cancer and the benefits of gene panels are expected to drive the growth of the global gene panel market. However, limitations in genetic panel testing and inaccuracy of the test are expected to hamper the growth of the market.



Segment Analysis

The Global Gene Panel Market has been segmented by product & service, Technique, Design, Application, and End User.

The market, based on product & service, has been bifurcated into test kits and testing services. Based on the technique, the global gene panel market has been bifurcated into the amplicon-based approach and hybridization-based approach. On the basis of design, the global gene panel market has been bifurcated into predesigned gene panels and customized gene panels. Based on the application, the global gene panel market has been classified as cancer risk assessment, diagnosis of congenital disorders and pharmacogenetics. The global gene panel market based on end-user has been divided into hospitals, diagnostic laboratories, and others.

Regional Analysis

The global gene panel market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are likely to hold the largest share of the global gene panel market during the assessment period. The rising prevalence of cancer and the presence of well-established players are expected to support the dominance of the Americas during the forecast period. Europe established substantial growth in the market owing to the incidence rates for all cancers projected to rise by 2% in the UK between 2014 and 2035, to 742 cases per 100,000 people by 2035. This rising case of cancer, along with improving the efficiency of gene panels, is expected to drive the growth of the market. Asia-Pacific is estimated to be the fastest-growing regional market due to the growing healthcare expenditure and the presence of a large patient pool. The gene panel market in the Middle East & Africa is expected to witness gradual growth due to the increasing healthcare expenditure, rising investments by major market players, and growing patient pool in this region. For instance, according to the International Trade Administration, health expenditure in the UAE was USD 17 billion in 2017 and is expected to reach USD 21.3 billion by 2021.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Gene Panel Market— Agilent Technologies Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Illumina Inc. (US), BGI Genomics (China), Integrated DNA Technologies, Inc. (the US), GENEWIZ (US), Novogene Corporation (US), Personalis, Inc. (the US), GATC Biotech AG (Germany), ArcherDX, Inc. (the US), GeneDx (Switzerland), and CENTOGENE AG (Germany).

Key Findings of the Study

The Global Gene Panel Market was valued at USD 1,988.76 Million in 2018 and is expected to register a CAGR of 12.16% during the assessment period of 2019 to 2025

The Americas accounted for the largest share of the global market

Based on the product & service, the testing services segment is expected to register the highest CAGR of 12.29% during the forecast period

Based on the technique, the amplicon-based approach segment is expected to register the highest CAGR of 12.52% during the forecast period

Based on the design, the predesigned gene panels segment accounted for the largest market share of 6% in 2018

Based on application, the cancer risk assessment segment accounted for a larger market share of 67.8% in 2018

Based on the end-user, the hospital's segment is expected to register the highest CAGR of 12.68% during the forecast period

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Custom Antibody Market Competitive landscape, future, growth till 2027

Image
  The Global Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period .The custom antibody provides high specificity and selectivity, these are easy to produce as compared to other antibodies and are hence the preferred choice in all types of research studies. Rising geriatric population, growing R&D investment and number of drugs in the pipeline are further anticipated to fuel the market growth. Growth in this segment is mostly driven by the need for high-quality antibodies for research reproducibility and producing high-quality therapeutics. Segmentation: The Global Custom Antibody Market has been segmented on the basis of service, source, type, research area and end users.On the basis of service, the market has been classified as custom antibody development , antibody production & purification, antibody fragmentation & labeling. The antibody development is segmented in to antibody characterization, antigen prep...
Read more

Body Contouring Market Research, Agency, Business Opportunities with New Players

Image
  According to the reports on the global Body Contouring Market , Market Research Future (MRFR) claims that the market is expecting a CAGR of 9.8 % during the forecast period (2017-2023). Body contouring is the process of altering a body part to give it a definitive shape and improving the appearance. The process often includes removal or transfer of fat. Thigh, abdomen, and buttocks often go under the knife to get this sort of fat removed. The global body contouring market is expecting a good prospect in the coming years as the improved safety and efficacy of these procedures are ensuring more takers for the market. At the same time, media and entertainment in many cases are playing an important role in pushing this notion forward of maintaining a distinct shape. Rising health-awareness is also promoting such notions. At the same time, technology is also having a significant impact on the global market. Products have now become easy-to-use, cost-effective, and less painful owing...
Read more